4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-079248
Chief Financial Officer bought 33,000 shares at $1.62 ($53,460)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wood Gavin Chief Financial Officer | 2020-06-29 | Purchase | +33,000 | $1.62 | $53,460 | 33,000 | D |
| Open-market purchases · 33,000 sh · avg $1.62 · $53,460 | |||||||
Loading xslF345X03/a4.xml…